Kowalsky Matthew Paul
Enanta Pharmaceuticals Inc · Chief Legal Officer
Kowalsky Matthew Paul is listed in public filings as officer: Chief Legal Officer. This Kowalsky Matthew Paul insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Enanta Pharmaceuticals Inc (ENTA). Investors use Kowalsky Matthew Paul's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --1.3k shares | Grant / ExerciseFeb 12, 2026 | Disclosure amount unavailable1.3k shares | -- | -- | |
| --5.5k shares | Grant / ExerciseFeb 12, 2026 | Disclosure amount unavailable4.2k shares | -- | -- | |
| $51k3.6k shares | Grant / ExerciseFeb 12, 2026 | $27.1K1.9k shares | $14.25 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.2M90k shares | Grant / ExerciseNov 25, 2025 | $1.2M90k shares | $13.66 | -- | |
| $662k75k shares | Grant / ExerciseNov 27, 2024 | $662.3K75k shares | $8.83 | -- |